Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Town Hall Teleconferences

CDC Vital Signs


Next Town Hall Teleconference

New CDC Data Tool: Antibiotic Resistance & Healthcare-Associated Infections — March 8, 2016


About Vital Signs Town Hall Conferences

On the second Tuesday of each month at 2–3 pm (ET), OSTLTS hosts a town hall teleconference about the topic of the latest CDC Vital Signs report. These monthly reports offer recent data and calls to action on important public health topics, and the teleconferences feature lessons learned and success stories from the state, tribal, local, or territorial perspective.

The town hall teleconferences were designed to provide a forum for our nation's health officials to broaden the conversation, build momentum, and carry out evidence-based, effective programs within the public health areas covered by Vital Signs. We hope the town halls are relevant and useful to you in your work to protect and improve the health of the public. We welcome your feedback at

Past Town Hall Teleconferences

Partnering to Prevent Alcohol Use During Pregnancy: A Call to Action

Alcohol use during pregnancy can cause fetal alcohol spectrum disorders (FASDs), which are physical, behavioral, and intellectual disabilities that last a lifetime. This teleconference featured a Vital Signs summary and discussion about alcohol and pregnancy.

E-cigarettes, Advertising, and Youth: A Public Health Priority

Eighteen million youth were exposed to electronic cigarette, or e-cigarette, advertisements in 2014. During the time e-cigarette ads have increased, there have also been increases in e-cigarette use among US youth. Exposure to e-cigarette ads may be contributing to increases in e-cigarette use among youth. This teleconference featured a Vital Signs summary and discussion about youth exposure to e-cigarette advertising.

Daily Pill Can Prevent HIV: Reaching People Who Could Benefit from PrEP

Preexposure prophylaxis (PrEP) is a medicine that can prevent HIV infection when taken every day. Daily PrEP can reduce the risk of getting HIV from sex by more than 90%, and can reduce HIV risk among people who inject drugs by more than 70%. Still, 1 in 3 primary care doctors and nurses haven't heard about PrEP. Learn more about PrEP by listening to this teleconference featuring a Vital Signs summary and discussion about PrEP for HIV prevention.


Share on your web page

CDC Vital Signs™ – Learn about the latest public health data. Read CDC Vital Signs™…

More Buttons Available

  • Page last reviewed: February 12, 2016
  • Page last updated: February 12, 2016
  • Content source:
    • Office for State, Tribal, Local and Territorial Support